# The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy

> **NCT01063881** · PHASE3 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 285 (actual)

## Conditions studied

- Sexual Dysfunction, Physiological

## Interventions

- **DRUG:** Dapoxetine

## Key facts

- **NCT ID:** NCT01063881
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-22
- **Primary completion:** 2011-06-14
- **Final completion:** 2011-06-14
- **Target enrollment:** 285 (ACTUAL)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063881, "The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01063881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*